Open AccessFEATURES OF THE RUSSIAN PHARMACEUTICAL MARKET
Author(s) -
А.И. Овод
Publication year - 2021
Publication title -
azimut naučnyh issledovanij: èkonomika i upravlenie
Language(s) - English
Resource type - Journals
eISSN - 2712-8482
pISSN - 2309-1762
DOI - 10.26140/anie-2021-1001-0057
Subject(s) - business , pharmaceutical industry , industrial organization , value (mathematics) , domestic market , distribution (mathematics) , order (exchange) , identification (biology) , drug prices , international trade , economics , public economics , finance , computer science , medicine , mathematical analysis , botany , mathematics , machine learning , pharmacology , biology
The pharmaceutical market in Russia in the current environment is one of the most dynamically developing, which is associated with its high importance for ensuring national security. The change in the foreign policy environment against the background of the events of 2014 showed the negative aspects of the country's previously existing dependence on the import of pharmaceutical products, defining the implementation of the import substitution strategy in the field of drug supply as a long-term benchmark for the development of the industry. However, its implementation actually ran into a number of difficulties, the most important of which is the insufficient level of development of the country's scientific and technical potential in this industry. In the course of the study, the analysis of the main indicators of the dynamics and structure of the domestic pharmaceutical market in physical and value terms, identification of the main trends and their causes was carried out. It has been established that in the past 3 years the domestic pharmaceutical market has been developing, which is confirmed by a steady trend towards an increase in its value from 1.6 to 1.8 trillion. rub. At the same time, generic drugs predominate in the market structure in 2019, accounting for more than 85% of the total number of packs sold, the cost of which amounted to about 60% of the total sales. Consequently, on the Russian pharmaceutical market, there is a tendency towards active distribution of generic drugs of domestic origin, which is due to their price advantage compared to original imported drugs, which are expensive and have problems with implementation under conditions of economic sanctions.